C. R. M. Hay
- Hematology top 0.05%
- Hemophilia Treatment and Research 100
- Platelet Disorders and Treatments 56
- Blood Coagulation and Thrombosis Mechanisms 51
- Chronic Myeloid Leukemia Treatments 20
- Hemostasis and retained surgical items 18
- Genetics top 0.5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 23
- Myeloproliferative Neoplasms: Diagnosis and Treatment 15
- Venomous Animal Envenomation and Studies 9
- Internal Medicine top 2%
- Virology top 2%
- Genetics top 2%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 23
- Myeloproliferative Neoplasms: Diagnosis and Treatment 15
- Venomous Animal Envenomation and Studies 9
- Co-authors
- Peter W. CollinsDonna DiMicheleDavid KeelingRi LiesnerKevin DochertyAura S. KamigutiMirko ZuzelClaude Négrier
- Cited by
- HematologyGeneticsInternal Medicine
- Journals
- The Lancet (1 paper)Nucleic Acids Research (1 paper)Journal of Biological Chemistry (2 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
C. R. M. Hay
172 papers receiving 7.3k citations
Peers
Comparison fields: 5 of 136
- Hematology 5.6k
- Genetics 1.7k
- Internal Medicine 246
- Virology 281
- Genetics 1000
Countries citing papers authored by C. R. M. Hay
This map shows the geographic impact of C. R. M. Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. R. M. Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. R. M. Hay more than expected).
Fields of papers citing papers by C. R. M. Hay
This network shows the impact of papers produced by C. R. M. Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. R. M. Hay. The network helps show where C. R. M. Hay may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. R. M. Hay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 17 | |
| 3 | A WITHIN-PATIENT COMPARISON OF EFFICACY AND OUTCOME OF RECOMBINANT FIX AND FIXFC IN HAEMOPHILIA B IN THE UK | 2020 | 2 |
| 4 | 2020 | 14 | |
| 5 | 2018 | 17 | |
| 6 | 2014 | 81 | |
| 7 | Inhibitor eradication therapy in non-severe hemophilia A | 2013 | 1 |
| 8 | 2012 | 201 | |
| 9 | 2012 | 13 | |
| 10 | 2011 | 322 | |
| 11 | 2011 | 140 | |
| 12 | 2007 | 19 | |
| 13 | 2006 | 82 | |
| 14 | 2006 | 13 | |
| 15 | 2005 | 5 | |
| 16 | 2004 | 211 | |
| 17 | 2004 | 49 | |
| 18 | 2000 | 108 | |
| 19 | 1991 | 8 | |
| 20 | Mathematics from manuscript to print, 1300-1600 | 1988 | 23 |
About C. R. M. Hay
C. R. M. Hay is a scholar working on Hematology, Genetics and Theoretical Computer Science, having authored 176 papers that have together received 7.6k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (100 papers), Platelet Disorders and Treatments (56 papers), Blood Coagulation and Thrombosis Mechanisms (51 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (23 papers), Chronic Myeloid Leukemia Treatments (20 papers), Hemostasis and retained surgical items (18 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (15 papers) and Venomous Animal Envenomation and Studies (9 papers). The work is most often cited by research in Hematology (5.6k citations), Genetics (1.7k citations) and Internal Medicine (246 citations). C. R. M. Hay has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Peter W. Collins, Donna DiMichele, David Keeling, Ri Liesner, Kevin Docherty, Aura S. Kamiguti, Mirko Zuzel, Claude Négrier, A. M. Cumming and Simon Brown. Their work appears in journals such as The Lancet, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.